Arsenal Medical

Drug Discovery · Waltham, MA · Founded 2005 · Privately Held (backing)

Developer of novel therapeutic in-situ forming materials designed to improve the clinical-stage drug delivery system. Arsenal Medical is based in Waltham, MA and was founded in 2005. It was valued at $124 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $46.8 million across 4 recorded rounds; the latest was a $6 million early-stage round in May 2019.

PMV mark · valuation
$124.0M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$46.8M
Last round
Early Stage VC
May 2019

Who backs Arsenal Medical?

7 investors
InvestorType
MedTech InnovatorOther
Springboard EnterprisesOther
National Institutes of HealthOther
Polaris PartnersVenture capital
North Bridge Venture PartnersVenture capital
Intersouth Partners—
U.S. Department of Commerce—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Arsenal Medical investors

7 investors are on record for Arsenal Medical, including MedTech Innovator, Springboard Enterprises, National Institutes of Health and Polaris Partners. The early-stage round in May 2019 drew 12 investors.

Free account
More of Arsenal Medical with a free account
  • ·Watch Arsenal Medical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like Arsenal Medical in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View